Literature DB >> 17917101

Solitary iris metastasis from breast cancer with dramatic course: case report.

Banu Ozturk1, Suleyman Buyukberber, Ugur Coskun, Emel Yaman, Ramazan Yildiz, Ali Osman Kaya, Yusuf Oner, Mustafa Benekli.   

Abstract

Intraocular metastases are the most common malignancy of eye. Breast cancer is more frequently a cause of intraocular metastases. As a first metastatic site, iris and ciliary body are relatively rare. We report a case of a 52-year-old woman, operated for breast cancer 16 months ago and diagnosed multiple brain metastases 1 month ago. After first course of chemotherapy she was admitted to hospital with the complaints of eye pain and she recognized a solid mass on iris. Iris and ciliary metastases were diagnosed by ophthalmological examination. Because of the patient's poor general condition, diagnostic aspiration from eye metastasis could not be performed. Intramedullary mass was determined 1 month later and she died 2 months later. Ciliary body and iris metastases of breast cancer must be considered as a manifestation of aggressive clinical course and poor prognosis. The eye metastases of breast cancer are a part of systemic illness and must be treated by systemic chemotherapy.

Entities:  

Mesh:

Year:  2007        PMID: 17917101     DOI: 10.1007/s12032-007-0019-7

Source DB:  PubMed          Journal:  Med Oncol        ISSN: 1357-0560            Impact factor:   3.064


  13 in total

1.  Breast cancer metastatic to the eye is a common entity.

Authors:  C F Merrill; D I Kaufman; N V Dimitrov
Journal:  Cancer       Date:  1991-08-01       Impact factor: 6.860

2.  Ocular metastases from breast carcinoma: A multicentric retrospective study.

Authors:  M Amichetti; O Caffo; E Minatel; M Roncadin; M C Valli; L Lozza; G Panizzoni
Journal:  Oncol Rep       Date:  2000 Jul-Aug       Impact factor: 3.906

3.  [Solitary iris metastasis from breast cancer. Effective local therapy with electron beam irradiation].

Authors:  M Martin; D Zierhut; M Piroth; S Gutwein; J Debus; S Dithmar
Journal:  Ophthalmologe       Date:  2006-01       Impact factor: 1.059

4.  Anterior uveal and episcleral metastases from carcinoma of the breast.

Authors:  S C Reddy; M Madhavan; S S Mutum
Journal:  Ophthalmologica       Date:  2000 Sep-Oct       Impact factor: 3.250

5.  Survey of 520 eyes with uveal metastases.

Authors:  C L Shields; J A Shields; N E Gross; G P Schwartz; S E Lally
Journal:  Ophthalmology       Date:  1997-08       Impact factor: 12.079

6.  Management of Ocular Metastasis.

Authors: 
Journal:  Cancer Control       Date:  1998-07       Impact factor: 3.302

Review 7.  [Localization and clinical characteristics of the ocular metastases of solid extraocular tumours].

Authors:  Katarzyna Królewska; Olgierd Palacz; Stanisław Zajaczek
Journal:  Klin Oczna       Date:  2004

8.  A histopathologic study of 716 unselected eyes in patients with cancer at the time of death.

Authors:  C C Nelson; B S Hertzberg; G K Klintworth
Journal:  Am J Ophthalmol       Date:  1983-06       Impact factor: 5.258

9.  Ocular metastases from breast carcinoma.

Authors:  Alberto Mejía-Novelo; Alberto Alvarado-Miranda; Flavia Morales-Vázquez; Carlos Gamboa-Vignole; Rodrigo Núñez-Gómez; Noel Castañeda-Soto; Alfonso Dueñas-González; Myrna Candelaria-Hernández; Fernando Lara-Medina
Journal:  Med Oncol       Date:  2004       Impact factor: 3.064

10.  Uveal metastasis from breast cancer in 264 patients.

Authors:  Hakan Demirci; Carol L Shields; An-Ning Chao; Jerry A Shields
Journal:  Am J Ophthalmol       Date:  2003-08       Impact factor: 5.258

View more
  2 in total

1.  The MRI findings of iris metastasis in patients with breast cancer.

Authors:  Hasan Mutlu; Zeki Akça; Abdullah Büyükçelik; Mustafa Oztürk; Mustafa Taşdemir; Alper Kubilay Yazıcıoğlu; Bünyamin Kaplan; Kadir Uçar
Journal:  Acta Inform Med       Date:  2012-12

Review 2.  Rare sites of breast cancer metastasis: a review.

Authors:  Rosa Di Micco; Letizia Santurro; Maria Luisa Gasparri; Veronica Zuber; Enrico Fiacco; Guglielmo Gazzetta; Chanel Elisha Smart; Alice Valentini; Oreste Davide Gentilini
Journal:  Transl Cancer Res       Date:  2019-10       Impact factor: 1.241

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.